Sexually transmitted infections (STI) are commonly underdiagnosed. Molecular methods have improved detection rates, especially among asymptomatic individuals, and has subsequently replaced conventional culture and serology. Despite the availability of syndromic management approach, many patients will present with non-specific symptoms that could lead to incorrect management or missed cases among asymptomatic individuals. STI co-infections are also common and STIs are known to increase the infectiousness of HIV. Screening remains important in high-risk individuals and contacts. Targeted therapy is preferred especially considering recent changes in management guidelines due to the emergence of resistance among these pathogens.
Solutions for diagnosing Sexually Transmitted Infections (STI)